Clinical Characteristics and Long-term Follow-up of Patients With Renal Vein Thrombosis

American Journal of Kidney Diseases

Volumn 51, Issue 2, 2008, Pages 224-232

  Wysokinski, Waldemar E ^a   Gosk Bierska, Izabela ^b   Greene, Eddie L ^a   Grill, Diane ^a   Wiste, Heather ^a   McBane II, Robert D ^a  

^a MAYO CLINIC   (United States)

^b WROCLAW MEDICAL UNIVERSITY   (Poland)

Author keywords

nephrotic syndrome; renal cell cancer; Renal vein thrombosis

Indexed keywords

ANTICOAGULANT AGENT; HEPARIN; WARFARIN;

ADULT; AGED; ARTICLE; CLINICAL FEATURE; CONFIDENCE INTERVAL; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; DEMOGRAPHY; FEMALE; FOLLOW UP; HUMAN; INCIDENCE; KIDNEY VEIN THROMBOSIS; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; NEPHROTIC SYNDROME; PRACTICE GUIDELINE; PRESCRIPTION; RECURRENT DISEASE; SURVIVAL; THROMBOPHILIA; TREATMENT OUTCOME;

ADULT; AGED; ANTICOAGULANTS; CASE-CONTROL STUDIES; COHORT STUDIES; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; FOLLOW-UP STUDIES; HUMANS; KIDNEY NEOPLASMS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEPHROTIC SYNDROME; ODDS RATIO; RECURRENCE; RENAL VEINS; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; SURVIVAL RATE; UNITED STATES; VENOUS THROMBOEMBOLISM; VENOUS THROMBOSIS; WARFARIN;

EID: 38349043747     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.ajkd.2007.10.030     Document Type: Article

References (30)

1. Rosenmann E., Pollak V.E., and Pirani C.L. Renal vein thrombosis in the adult: A clinical and pathologic study based on renal biopsies. Medicine 47 (1968) 269-335
2. Duncan R.E., Evans A.T., and Martin L.W. Natural history and treatment of renal vein thrombosis in children. J Pediatr Surg 12 (1977) 639-645
3. Zucchelli P. Renal vein thrombosis. Nephrol Dial Transplant 7 suppl 1 (1992) S105-S108
4. Llach F., Papper S., and Massry S.G. The clinical spectrum of renal vein thrombosis: Acute and chronic. Am J Med 69 (1980) 819-827
5. Laville M., Aguilera D., Maillet P.J., et al. The prognosis of renal-vein thrombosis. A re-evaluation of 27 cases. Nephrol Dial Transplant 3 (1988) 247-256
6. McCarthy L.J., Titus J.L., and Daugherty G.W. Bilateral renal vein thrombosis and the nephrotic syndrome in adults. Ann Intern Med 58 (1963) 837-849
7. Kanfer A., Fleinknetch D., Broyer M., et al. Coagulation studies in 45 cases of nephrotic syndrome without uremia. Thromb Diathes Haemorrh 24 (1970) 562-568
8. Thompson C., Forbes C.D., Prentice C.R.M., et al. Changes in blood coagulation and fibrinolysis in the nephrotic syndrome. Q J Med 43 (1974) 399-412
9. Thaler E., Blazar E., Kopsa H., et al. Acquired antithrombin III deficiency in patients with glomerular proteinuria. Hemostasis 7 (1978) 257-262
10. Vigano-D'Angelo S., D'Angelo A., Kauffman C.E., et al. Protein S deficiency occurs in the nephrotic syndrome. Am Inter Med 107 (1987) 42-51
11. Sturgill B.C., and Rowe C.T. Renal vein thrombosis and the nephrotic syndrome. Immunofluorescence studies. Arch Intern Med 120 (1967) 708-711
12. Trew P.A., Biava C.G., Jacobs R.P., and Hopper J. Renal vein thrombosis in membranous glomerulonephropathy: Incidence and association. Medicine 57 (1978) 69-82
13. Briefel G.R., Manis T., and Gordon D.H. Recurrent renal vein thrombosis consequent to membranous nephropathy. Clin Nephrol 10 (1978) 32-39
14. Llach R. Nephrotic syndrome: Hypercoagulability, renal vein thrombosis, and other thromboembolic complications. In: Brenner B., and Stein J. (Eds). Contemporary Issues in Nephrology vol 9 (1982), Churchill-Livingston, New York, NY 121-144
15. Belman A.B., Susmano D.F., Burden J.J., et al. Nonoperative treatment of unilateral renal vein thrombosis in the newborn. JAMA 211 (1970) 1165-1168
16. Zigman A., Yazbeck S., Emil S., and Nguyen L. Renal vein thrombosis: A 10-year review. J Pediatr Surg 35 (2000) 1540-1542
17. Seeler R.A., Kapadia P., and Moncado R. Nonsurgical management of thrombosis of bilateral renal veins and inferior vena cava in a newborn infant. Clin Pediatr 9 (1970) 543-547
18. Therneau T., Sicks J., Bergstralh E., and Offord J. Expected Survival Based on Hazard Rates. Technical Report Series No. 52 (1994), Section of Biostatistics, Mayo Clinic, Rochester, MN
19. Heit J.A., Silverstein M.D., Mohr D.N., Petterson T.M., O'Fallon W.M., and Melton III L.J. Predictors of survival after deep vein thrombosis and pulmonary embolism: A population-based, cohort study. Arch Intern Med 159 (1999) 445-453
20. Silverstein M.D., Heit J.A., Mohr D.N., et al. Trends in the incidence of deep vein thrombosis and pulmonary embolism: A 25-year population-based study. Arch Intern Med 158 (1998) 585-593
21. Heit J.A., Mohr D.N., Silverstein M.D., et al. Predictors of recurrence after deep vein thrombosis and pulmonary embolism: A population-based cohort study. Arch Intern Med 160 (2000) 761-768
22. Singhal R., and Brimble K.S. Thromboembolic complications in the nephrotic syndrome: Pathophysiology and clinical management. Thromb Res 118 (2006) 397-407
23. Vaziri N.D., Paule P., Toohey J., et al. Acquired deficiency and urinary excretion of antithrombin III in nephrotic syndrome. Arch Intern Med 144 (1984) 1802-1803
24. Toulon P., Gandrille S., Remy P., Chadeuf G., Jouvin M.H., and Aiach M. Significance of high levels of heparin cofactor II in the plasma and urine of adult patients with nephrotic syndrome. Nephron 60 (1992) 176-180
25. Lau S.O., Tkachuck J.Y., Hasegawa D.K., and Edson J.R. Plasminogen and antithrombin III deficiencies in the childhood nephrotic syndrome associated with plasminogenuria and antithrombinuria. J Pediatr 96 (1980) 390-392
26. Büller H.R., Agnelli G., Hull R.D., et al. Antithrombotic therapy for venous thromboembolic disease: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 126 suppl 3 (2004) S401-S428
27. Schulman S., Granqvist S., Holmstrom M., et al. The duration of oral anticoagulant therapy after a second episode of venous thromboembolism. N Engl J Med 336 (1997) 393-398
28. Kearon C., Ginsberg J., Kovacs M., et al. Comparison of low-intensity warfarin therapy with conventional-intensity warfarin therapy for long-term prevention of recurrent venous thromboembolism. N Engl J Med 349 (2003) 631-639
29. Ridker P.M., Goldhaber S.Z., Danielson E., et al., PREVENT Investigators. Long-term, low-intensity warfarin therapy for the prevention of recurrent venous thromboembolism. N Engl J Med 348 (2003) 1425-1434
30. Agnelli G., Prandoni P., Santamaria M.G., et al. Three months versus one year of oral anticoagulant therapy for idiopathic deep venous thrombosis. N Engl J Med 345 (2001) 165-169